Xiangbo Kong

China Japan Union Hospital
Changchun, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Mini Percutaneous Nephrolithotomy Is a Noninferior Modality to Standard Percutaneous Nephrolithotomy for the Management of 20-40mm Renal Calculi: A Multicenter Randomized Controlled Trial.

Mini Percutaneous Nephrolithotomy Is a Noninferior Modality to Standard Percutaneous Nephrolithotomy for the Management of 20-40mm Renal Calculi: A Multicenter Randomized Controlled Trial.

Journal: European urology

Published: May 04, 2020

Effect of adjuvant hormone therapy in patients with prostate cancer: A meta-analysis of randomized controlled trials.

Effect of adjuvant hormone therapy in patients with prostate cancer: A meta-analysis of randomized controlled trials.

Journal: Medicine

Published: December 19, 2018

Laparoscopic versus open nephroureterectomy for upper urinary tract urothelial carcinoma: A systematic review and meta-analysis.

Laparoscopic versus open nephroureterectomy for upper urinary tract urothelial carcinoma: A systematic review and meta-analysis.

Journal: Medicine

Published: September 02, 2018

miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5.

miR-488 inhibits cell growth and metastasis in renal cell carcinoma by targeting HMGN5.

Journal: OncoTargets and therapy

Published: May 02, 2018

MicroRNA-384 Inhibits the Growth and Invasion of Renal Cell Carcinoma Cells by Targeting Astrocyte Elevated Gene 1.

MicroRNA-384 Inhibits the Growth and Invasion of Renal Cell Carcinoma Cells by Targeting Astrocyte Elevated Gene 1.

Journal: Oncology research

Published: September 08, 2017

Identification of a Novel UT-B Urea Transporter in Human Urothelial Cancer.

Identification of a Novel UT-B Urea Transporter in Human Urothelial Cancer.

Journal: Frontiers in physiology

Published: January 31, 2017

MicroRNA‑613 inhibits proliferation and invasion of renal cell carcinoma cells through targeting FZD7.

MicroRNA‑613 inhibits proliferation and invasion of renal cell carcinoma cells through targeting FZD7.

Journal: Molecular medicine reports

Published: September 07, 2016

Prognostic analysis of Chinese patients with metastasis renal cell cancer receiving sorafenib: results from a multicenter long-term follow-up retrospective study.

Prognostic analysis of Chinese patients with metastasis renal cell cancer receiving sorafenib: results from a multicenter long-term follow-up retrospective study.

Journal: OncoTargets and therapy

Published: July 15, 2015

Current status of diagnosis and treatment of bladder cancer in China - Analyses of Chinese Bladder Cancer Consortium database.

Current status of diagnosis and treatment of bladder cancer in China - Analyses of Chinese Bladder Cancer Consortium database.

Journal: Asian journal of urology

Published: December 02, 2014

Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer.

Beneficial effect of T follicular helper cells on antibody class switching of B cells in prostate cancer.

Journal: Oncology reports

Published: September 11, 2014

Prostate cancer in Asia: A collaborative report.

Prostate cancer in Asia: A collaborative report.

Journal: Asian journal of urology

Published: July 15, 2014

Selective expression of tumor necrosis factor-related apoptosis-inducing ligand mediated by microRNA suppresses renal carcinoma growth.

Selective expression of tumor necrosis factor-related apoptosis-inducing ligand mediated by microRNA suppresses renal carcinoma growth.

Journal: Molecular and cellular biochemistry

Published: December 18, 2013

Showing 1-12 of 19

Last Updated: 09/26/2026